These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28719060)

  • 21. Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada.
    Jacka B; Roy É; Høj S; Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Bruneau J
    J Viral Hepat; 2019 Dec; 26(12):1413-1422. PubMed ID: 31433888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies.
    Bartlett SR; Wertheim JO; Bull RA; Matthews GV; Lamoury FM; Scheffler K; Hellard M; Maher L; Dore GJ; Lloyd AR; Applegate TL; Grebely J
    J Viral Hepat; 2017 May; 24(5):404-411. PubMed ID: 27882678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology of newly acquired hepatitis C infections in England 2008-2011: genotype, phylogeny and mutation analysis.
    May S; Ngui SL; Collins S; Lattimore S; Ramsay M; Tedder RS; Ijaz S
    J Clin Virol; 2015 Mar; 64():6-11. PubMed ID: 25728071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack.
    Macías J; Palacios RB; Claro E; Vargas J; Vergara S; Mira JA; Merchante N; Corzo JE; Pineda JA
    Liver Int; 2008 Jul; 28(6):781-6. PubMed ID: 18312289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.
    Puzhko S; Roy É; Jutras-Aswad D; Artenie AA; Fortier E; Zang G; Bruneau J
    Int J Drug Policy; 2017 Sep; 47():61-68. PubMed ID: 28666636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events.
    Olmstead AD; Joy JB; Montoya V; Luo I; Poon AF; Jacka B; Lamoury F; Applegate T; Montaner J; Khudyakov Y; Grebely J; Cook D; Harrigan PR; Krajden M
    Infect Genet Evol; 2015 Jul; 33():101-9. PubMed ID: 25917496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
    Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
    J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves.
    Di Lello FA; Neukam K; Parra-Sanchez M; Plaza Z; Soriano V; Cifuentes C; Mira JA; Poveda E; Pineda JA
    J Med Virol; 2013 Oct; 85(10):1734-40. PubMed ID: 23861220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polydrug Use and HIV Risk Among People Who Inject Heroin in Tijuana, Mexico: A Latent Class Analysis.
    Meacham MC; Rudolph AE; Strathdee SA; Rusch ML; Brouwer KC; Patterson TL; Vera A; Rangel G; Roesch SC
    Subst Use Misuse; 2015; 50(10):1351-9. PubMed ID: 26444185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
    Nevot M; Boesecke C; Parera M; Andrés C; Franco S; Revollo B; Ingiliz P; Tural C; Clotet B; Rockstroh JK; Martinez MA;
    J Viral Hepat; 2014 Jun; 21(6):e19-28. PubMed ID: 24674023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HCV dispersal patterns among intravenous drug users (IDUs) in Athens metropolitan area.
    Papachristou E; Tsagkovits A; Zavitsanou A; Hatzakis A; Paraskevis D
    Infect Genet Evol; 2016 Nov; 45():415-419. PubMed ID: 27721034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
    J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.
    Grebely J; Dalgard O; Cunningham EB; Hajarizadeh B; Foster GR; Bruggmann P; Conway B; Backmund M; Robaeys G; Swan T; Amin J; Marks PS; Quiene S; Applegate TL; Weltman M; Shaw D; Dunlop A; Hellard M; Bruneau J; Midgard H; Bourgeois S; Staehelin C; Dore GJ;
    Int J Drug Policy; 2017 Sep; 47():177-186. PubMed ID: 28624134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan.
    Sanders-Buell E; Rutvisuttinunt W; Todd CS; Nasir A; Bradfield A; Lei E; Poltavee K; Savadsuk H; Kim JH; Scott PT; de Souza M; Tovanabutra S
    J Med Virol; 2013 Jul; 85(7):1170-9. PubMed ID: 23918535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.
    Matheï C; Wollants E; Verbeeck J; Van Ranst M; Robaeys G; Van Damme P; Buntinx F
    Eur J Clin Microbiol Infect Dis; 2005 Aug; 24(8):514-22. PubMed ID: 16133411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015.
    Rossetti B; Bai F; Tavelli A; Galli M; Antinori A; Castelli F; Pellizzer G; Cozzi-Lepri A; Bonora S; Monforte AD; Puoti M; De Luca A;
    Clin Microbiol Infect; 2018 Apr; 24(4):422-427. PubMed ID: 28765078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
    J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transmission of Hepatitis C Virus among Prisoners, Australia, 2005-2012.
    Bretaña NA; Boelen L; Bull R; Teutsch S; White PA; Lloyd AR; Luciani F;
    Emerg Infect Dis; 2015 May; 21(5):765-74. PubMed ID: 25897788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited overlap between phylogenetic HIV and hepatitis C virus clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM.
    Vanhommerig JW; Bezemer D; Molenkamp R; Van Sighem AI; Smit C; Arends JE; Lauw FN; Brinkman K; Rijnders BJ; Newsum AM; Bruisten SM; Prins M; Van Der Meer JT; Van De Laar TJ; Schinkel J;
    AIDS; 2017 Sep; 31(15):2147-2158. PubMed ID: 28692530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Test uptake and hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: a registry-based cohort study.
    Øvrehus A; Nielsen S; Hansen JF; Holm DK; Christensen P
    Addiction; 2019 Mar; 114(3):494-503. PubMed ID: 30347471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.